TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07884864: A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AHB-121 Injection in Healthy and Chronic Hepatitis B Participants

Sponsor: Ausper Biopharma Co., Ltd. · Phase: PHASE1 · Area: INFECTIOUS_VACCINE · Target Enrollment: 110 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,397,440

Rescue Site Savings

+$4,218,312

Unlock Full NCT07884864 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07884864 Rescue Dossier →